Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or ?lot? of Intravenous Immunoglobulin.

Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.

Market Analysis and Insights: Global Intravenous Immunoglobulin (IVIg) Market

In 2020, the global Intravenous Immunoglobulin (IVIg) market size was US$ 9735.3 million and it is expected to reach US$ 14540 million by the end of 2027, with a CAGR of 5.9% during 2021-2027.

Global Intravenous Immunoglobulin (IVIg) Scope and Market Size

Intravenous Immunoglobulin (IVIg) market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Intravenous Immunoglobulin (IVIg) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Intravenous Immunoglobulin (IVIg) market is segmented into

  • IVIg Liquid
  • IVIg Powder

Segment by Application, the Intravenous Immunoglobulin (IVIg) market is segmented into

  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection

Regional and Country-level Analysis:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Competitive Landscape and Intravenous Immunoglobulin (IVIg) Market Share Analysis

Intravenous Immunoglobulin (IVIg) market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Intravenous Immunoglobulin (IVIg) product introduction, recent developments, Intravenous Immunoglobulin (IVIg) sales by region, type, application and by sales channel.

The major companies include:

  • Baxter
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang

Reasons to Purchase Our Research Report:

  • Analyzing the outlook of the market with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
  • Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • Analyst support, along with the data support in excel format.

Table of content

1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2016-2027
2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2016-2027
2.2 Intravenous Immunoglobulin (IVIg) Market Size by Region: 2021 Versus 2027
2.3 Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2027)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2016-2021
2.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2022-2027)
2.3.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2027)
2.4 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2016-2021
2.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2022-2027)

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Follow Us On linkedin :-